These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 26828)

  • 1. [Raynaud's phenomenon after treatment with beta-blocking agents].
    Eliasson K; Johnsson H; Kistner S; Lins LE; Odar-Cederlöf I; Sundqvist K
    Lakartidningen; 1978 May; 75(21):2118-20. PubMed ID: 26828
    [No Abstract]   [Full Text] [Related]  

  • 2. Raynaud's phenomenon caused by beta-receptor blocking drugs. Improvement after treatment with a combined alpha- and beta-blocker.
    Eliasson K; Danielson M; Hylander B; Lindblad LE
    Acta Med Scand; 1984; 215(4):333-9. PubMed ID: 6145298
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Beta-blockers, beta-stimulators and Raymaud's syndrome].
    Naess K
    Tidsskr Nor Laegeforen; 1973 Jun; 93(16):1255-6. PubMed ID: 4148082
    [No Abstract]   [Full Text] [Related]  

  • 4. Letter: Raynaud's phenomenon as side effect of beta-blockers.
    Marshall A; Barritt DW; Roberts CJ
    Br Med J; 1976 Jul; 2(6030):301. PubMed ID: 8186
    [No Abstract]   [Full Text] [Related]  

  • 5. Raynaud's phenomenon as side effect of beta-blockers in hypertension.
    Marshall AJ; Roberts CJ; Barritt DW
    Br Med J; 1976 Jun; 1(6024):1498-9. PubMed ID: 6109
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vasospastic phenomena in patients treated with beta-adrenoceptor blocking agents.
    Eliasson K; Lins LE; Sundqvist K
    Acta Med Scand Suppl; 1979; 628():39-46. PubMed ID: 37701
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Peripheral vascular complications of beta-blocking agents].
    Guilmot JL; Perrotin D; Constans T; Pasticier A
    J Mal Vasc; 1984; 9(1):59-62. PubMed ID: 6142917
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of Raynaud's phenomenon in patients with migraine.
    Zahavi I; Chagnac A; Hering R; Davidovich S; Kuritzky A
    Arch Intern Med; 1984 Apr; 144(4):742-4. PubMed ID: 6143540
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Raynaud's phenomenon after chemotherapy. Apropos of 3 cases].
    Adoue D; Arlet P; Vilain C; Le Tallec Y; Bonafé JL; de Lafontan B
    Ann Dermatol Venereol; 1985; 112(2):151-5. PubMed ID: 2408534
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Raynaud syndrome following timolol-containing eyedrops].
    Meuche C; Heidrich H; Bleckmann H
    Fortschr Ophthalmol; 1990; 87(1):45-7. PubMed ID: 2323696
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma beta-thromboglobulin in the differential diagnosis of Raynaud's phenomenon.
    Seibold JR; Harris JN
    J Rheumatol; 1985 Feb; 12(1):99-103. PubMed ID: 2580093
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Calcium antagonists and Raynaud's phenomenon].
    Hachulla E; Devulder B
    Therapie; 1993; 48 Spec No():707-11. PubMed ID: 8091357
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Diagnosis and treatment of Raynaud's phenomenon].
    Guilmot JL; Diot E; Lasfargues G
    Arch Mal Coeur Vaiss; 1991 Nov; 84(11 Suppl):1755-60. PubMed ID: 1685081
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bleomycin-induced Raynaud's phenomenon.
    Kukla LJ; Burrows D; Bressler L; McGuire WP
    Arch Dermatol; 1981 Oct; 117(10):604. PubMed ID: 6169311
    [No Abstract]   [Full Text] [Related]  

  • 15. [Diagnosis of Raynaud's phenomenon].
    Marie I
    Rev Prat; 2007 Oct; 57(15):1707-12; quiz 1712. PubMed ID: 18080433
    [No Abstract]   [Full Text] [Related]  

  • 16. [Raynaud's phenomenon induced by bleomycin: a clinical case].
    Niklander C; Guzmán L
    Rev Med Chil; 1988 Dec; 116(12):1302-5. PubMed ID: 2477885
    [No Abstract]   [Full Text] [Related]  

  • 17. Interferon-induced Raynaud's syndrome.
    Schapira D; Nahir AM; Hadad N
    Semin Arthritis Rheum; 2002 Dec; 32(3):157-62. PubMed ID: 12528080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term safety of receptor-blocking drugs.
    Lancet; 1978 Jun; 1(8076):1242-3. PubMed ID: 78004
    [No Abstract]   [Full Text] [Related]  

  • 19. Cyclosporine--a treatment and a rare complication: Raynaud's phenomenon.
    Arinsoy T; Derici U; Yuksel A; Reis KA; Sindel S
    Int J Clin Pract; 2005 Jul; 59(7):863-4. PubMed ID: 15963220
    [No Abstract]   [Full Text] [Related]  

  • 20. Raynaud's phenomenon possibly induced by a compund drug of tegafur and uracil.
    Seishima M; Izumi T; Kanoh H
    Eur J Dermatol; 2000; 10(1):55-8. PubMed ID: 10694301
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.